| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.003 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.004 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.093 | 0.004 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.005 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.094 | 0.006 |